EU Prioritises Allergic Diseases In The Seventh Framework Programme For Research
Main Category: AllergyAlso Included In: Respiratory / Asthma
Article Date: 23 Dec 2006 - 22:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
4 (1 votes) |
GA²LEN welcomes the vote of the European Parliament on the Seventh Framework Programme (FP7) on 30 November that acknowledges allergic diseases as major chronic diseases to be addressed in European research during the coming 7 years (2007 - 2013).
The European Parliament adopted the report of Prof. Jerzy Buzek that recognises “respiratory diseases including those induced by allergies” as health priorities to be addressed by translational research. This will allow respiratory allergic diseases (including asthma) to be covered by the research programme under the health theme.
In the first drafts, only food allergies (8% of all allergies) were covered. Allergic diseases will now be tackled under both the health and food themes of the research programme which should allow scientists to progress towards the overall understanding that is needed to help control this epidemic through effective prevention and treatment.
“Allergic diseases” in all their different aspects - from hay fever to fatal attacks of asthma or reactions to peanuts - are taking lives daily and creating huge financial costs. According to the World Health Organization, asthma kills someone in Europe every hour. One child in three is allergic today and by 2015, half of the European population may be suffering from one or more allergic condition.
The European Union’s next research programme known as the Seventh Framework Programme (FP7) begins on 1st January 2007 and will run for seven years until 2013 with a total budget of €54.6 billion.
GA²LEN - the Global Allergy and Asthma European Network is a “Network of Excellence” funded by the European Union 6th Research Framework Programme (FP6). It consists of 26 research centres spread throughout Europe, as well as the European Academy of Allergology and Clinical Immunology (EAACI) and the European Federation of Allergy and Airways Diseases Patients Associations (EFA). Close to 50 collaborating centres have joined the network since its launch in 2004.
http://www.ga2len.net
World Health Report 2003, “Shaping the Future”. World Health Organization
Visit our allergy section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/58995.php>
APA
http://www.medicalnewstoday.com/releases/58995.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




